{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:00:35Z","timestamp":1787061635150,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01HL112696"],"award-info":[{"award-number":["U01HL112696"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI087652"],"award-info":[{"award-number":["R01AI087652"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00408-017-0037-y","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T08:24:05Z","timestamp":1499934245000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort"],"prefix":"10.1007","volume":"195","author":[{"given":"Bryan S.","family":"Benn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Ramstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Arger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-3622","authenticated-orcid":false,"given":"Laura L.","family":"Koth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"issue":"2","key":"37_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","unstructured":"Statement on sarcoidosis (1999) Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2):736\u2013755","journal-title":"Am J Respir Crit Care Med"},{"issue":"9923","key":"37_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D et al (2014) Sarcoidosis. Lancet 383(9923):1155\u20131167","journal-title":"Lancet"},{"issue":"1","key":"37_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1378\/chest.10-0413","volume":"139","author":"YC Cozier","year":"2011","unstructured":"Cozier YC et al (2011) Sarcoidosis in black women in the United States: data from the Black Women\u2019s Health Study. Chest 139(1):144\u2013150","journal-title":"Chest"},{"issue":"2","key":"37_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1183\/09031936.00075307","volume":"31","author":"T Morimoto","year":"2008","unstructured":"Morimoto T et al (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31(2):372\u2013379","journal-title":"Eur Respir J"},{"issue":"6","key":"37_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1053\/rmed.1999.0579","volume":"93","author":"A Pietinalho","year":"1999","unstructured":"Pietinalho A et al (1999) Familial sarcoidosis in Finland and Hokkaido, Japan\u2014a comparative study. Respir Med 93(6):408\u2013412","journal-title":"Respir Med"},{"issue":"3","key":"37_CR6","first-page":"166","volume":"13","author":"BA Rybicki","year":"1998","unstructured":"Rybicki BA et al (1998) Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 13(3):166\u2013173","journal-title":"Semin Respir Infect"},{"issue":"1","key":"37_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","volume":"13","author":"O Dumas","year":"2016","unstructured":"Dumas O et al (2016) Epidemiology of sarcoidosis in a prospective cohort study of U.S. women. Ann Am Thorac Soc 13(1):67\u201371","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"37_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA et al (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145(3):234\u2013241","journal-title":"Am J Epidemiol"},{"issue":"8","key":"37_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP et al (2016) Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc 13(8):1244\u20131252","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"37_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","volume":"183","author":"RP Baughman","year":"2011","unstructured":"Baughman RP, Culver DA, Judson MA (2011) A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 183(5):573\u2013581","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"37_CR11","first-page":"119","volume":"29","author":"MA Judson","year":"2012","unstructured":"Judson MA, Boan AD, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 29(2):119\u2013127","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"37_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0002-9343(85)90463-2","volume":"78","author":"JM Reich","year":"1985","unstructured":"Reich JM, Johnson RE (1985) Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. Am J Med 78(1):61\u201367","journal-title":"Am J Med"},{"issue":"10 Pt 1","key":"37_CR13","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164(10 Pt 1):1885\u20131889","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"37_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","volume":"12","author":"DR Moller","year":"2015","unstructured":"Moller DR et al (2015) Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocol. Ann Am Thorac Soc 12(10):1561\u20131571","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"37_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","volume":"193","author":"J Ramstein","year":"2016","unstructured":"Ramstein J et al (2016) IFN-gamma-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper Type 1 cells. Am J Respir Crit Care Med 193(11):1281\u20131291","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"37_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1183\/09031936.00039714","volume":"44","author":"R Su","year":"2014","unstructured":"Su R et al (2014) Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J 44(4):985\u2013993","journal-title":"Eur Respir J"},{"issue":"2","key":"37_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319\u2013338","journal-title":"Eur Respir J"},{"issue":"538","key":"37_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/pgmj.46.538.530","volume":"46","author":"JG Scadding","year":"1970","unstructured":"Scadding JG (1970) The late stages of pulmonary sarcoidosis. Postgrad Med J 46(538):530\u2013536","journal-title":"Postgrad Med J"},{"issue":"5","key":"37_CR19","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948\u2013968","journal-title":"Eur Respir J"},{"issue":"3","key":"37_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","volume":"155","author":"A Qaseem","year":"2011","unstructured":"Qaseem A et al (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155(3):179\u2013191","journal-title":"Ann Intern Med"},{"issue":"4","key":"37_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1183\/09031936.04.00070503","volume":"24","author":"DL Rabin","year":"2004","unstructured":"Rabin DL et al (2004) Sarcoidosis: social predictors of severity at presentation. Eur Respir J 24(4):601\u2013608","journal-title":"Eur Respir J"},{"issue":"2","key":"37_CR22","first-page":"147","volume":"22","author":"H Yeager","year":"2005","unstructured":"Yeager H et al (2005) Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis Vasc Diffuse Lung Dis 22(2):147\u2013153","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"37_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0954-6111(06)80211-8","volume":"85","author":"BD Harrison","year":"1991","unstructured":"Harrison BD et al (1991) Airflow limitation in sarcoidosis\u2014a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 85(1):59\u201364","journal-title":"Respir Med"},{"issue":"2","key":"37_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1385\/CRIAI:25:2:115","volume":"25","author":"P Laohaburanakit","year":"2003","unstructured":"Laohaburanakit P, Chan A (2003) Obstructive sarcoidosis. Clin Rev Allergy Immunol 25(2):115\u2013129","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"37_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1183\/09031936.00103811","volume":"39","author":"M Thillai","year":"2012","unstructured":"Thillai M et al (2012) Obstructive lung function in sarcoidosis may be missed, especially in older white patients. Eur Respir J 39(3):775\u2013777","journal-title":"Eur Respir J"},{"issue":"5","key":"37_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/00063198-200209000-00013","volume":"8","author":"DG James","year":"2002","unstructured":"James DG, Sharma OP (2002) From Hutchinson to now: a historical glimpse. Curr Opin Pulm Med 8(5):416\u2013423","journal-title":"Curr Opin Pulm Med"},{"key":"37_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.iy.11.040193.001203","volume":"11","author":"PS Linsley","year":"1993","unstructured":"Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191\u2013212","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"37_CR28","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1073\/pnas.91.7.2834","volume":"91","author":"KV Prasad","year":"1994","unstructured":"Prasad KV et al (1994) T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci USA 91(7):2834\u20132838","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"37_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0092-8674(05)80055-8","volume":"71","author":"RH Schwartz","year":"1992","unstructured":"Schwartz RH (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7\/BB1 in interleukin-2 production and immunotherapy. Cell 71(7):1065\u20131068","journal-title":"Cell"},{"issue":"23","key":"37_CR30","doi-asserted-by":"publisher","first-page":"11194","DOI":"10.1073\/pnas.89.23.11194","volume":"89","author":"JD Siliciano","year":"1992","unstructured":"Siliciano JD, Morrow TA, Desiderio SV (1992) itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci USA 89(23):11194\u201311198","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"37_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1101\/gad.5.5.880","volume":"5","author":"A Travis","year":"1991","unstructured":"Travis A et al (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected]. Genes Dev 5(5):880\u2013894","journal-title":"Genes Dev"},{"issue":"5","key":"37_CR32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.rmed.2012.01.012","volume":"106","author":"H Ahmadzai","year":"2012","unstructured":"Ahmadzai H et al (2012) Peripheral blood responses to specific antigens and CD28 in sarcoidosis. Respir Med 106(5):701\u2013709","journal-title":"Respir Med"},{"issue":"11","key":"37_CR33","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","volume":"190","author":"KA Oswald-Richter","year":"2013","unstructured":"Oswald-Richter KA et al (2013) Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis. J Immunol 190(11):5446\u20135453","journal-title":"J Immunol"},{"issue":"11","key":"37_CR34","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","volume":"164","author":"BA Rybicki","year":"2001","unstructured":"Rybicki BA et al (2001) Familial aggregation of sarcoidosis. A case\u2013control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164(11):2085\u20132091","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR35","doi-asserted-by":"crossref","unstructured":"Lareau CA et al (2017) Polygenic risk assessment reveals pleiotropy between sarcoidosis and inflammatory disorders in the context of genetic ancestry. Genes Immun","DOI":"10.1038\/gene.2017.3"},{"key":"37_CR36","doi-asserted-by":"crossref","unstructured":"Morais A et al (2016) Associations between sarcoidosis clinical course and ANXA11 rs1049550 C\/T, BTNL2 rs2076530 G\/A, and HLA class I and II alleles. Clin Respir J","DOI":"10.1111\/crj.12559"},{"issue":"1","key":"37_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13023-016-0546-4","volume":"11","author":"Y Pacheco","year":"2016","unstructured":"Pacheco Y et al (2016) Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort. Orphanet J Rare Dis 11(1):165","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"37_CR38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1164\/rccm.201507-1372OC","volume":"193","author":"NV Rivera","year":"2016","unstructured":"Rivera NV et al (2016) High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences. Am J Respir Crit Care Med 193(9):1008\u20131022","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-017-0037-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-017-0037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-017-0037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:23:32Z","timestamp":1589682212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-017-0037-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s00408-017-0037-y","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]},"assertion":[{"value":"1 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Gelfand reports personal compensation for consulting on a scientific advisory board for Genentech, personal compensation for medical legal consulting, and research support to UCSF from Quest Diagnostics, Genentech, and MedDay. All the other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Animal Studies"}}]}}